Financials
| Interim Results | Sep. 24, 2024 |
| Final Results | Apr. 23, 2024 |
| Interim Results | Sep. 12, 2023 |
| Final Results | Mar. 09, 2023 |
| Interim Results | Sep. 29, 2022 |
| Final Results | Feb. 23, 2022 |
| Interim Results | Sep. 20, 2021 |
Proxies
| Result of AGM | Jun. 30, 2025 |
| AGM Statement | Jun. 30, 2025 |
| Result of AGM | May. 23, 2024 |
| Posting of Annual Report & Notice of AGM | Apr. 29, 2024 |
| Result of AGM | Apr. 03, 2023 |
| Posting of Annual Report & Notice of AGM | Mar. 09, 2023 |
| Result of AGM | Mar. 24, 2022 |
Ownership Update
| TR-1: Notification of major holdings | May. 23, 2025 |
| Holding(s) in Company | May. 21, 2025 |
| Holding(s) in Company | May. 09, 2025 |
| Holding(s) in Company | Apr. 29, 2025 |
| Holding(s) in Company | Apr. 29, 2025 |
| Holding(s) in Company | Apr. 28, 2025 |
| TR-1: Standard form notification of major holdings | Apr. 23, 2025 |
Announcements
| Article on Nuvec®’s Potential in RNA Therapeutics | Jul. 30, 2025 |
| Investor Webinar | Jul. 14, 2025 |
| Directorate Change | Jul. 08, 2025 |
| Insight Event for Retail Investors | Jun. 25, 2025 |
| Establishment of New Senior Leadership Team | May. 27, 2025 |
| Change of Registered Address | May. 15, 2025 |
| N4 101 In Vivo Study Results | May. 12, 2025 |